PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

ArisGlobal® Expands its Safety and Risk Management Offerings with Acquisition of Medsight Sapphire

STAMFORD, CT – 15th June 2015, ArisGlobal®, a leading provider of Cloud solutions to life sciences companies, is pleased to announce that it has acquired Medsight Solutions, including the revolutionary integrated risk management solution, Medsight Sapphire (now known as ArisGlobal agBalance™). The ArisGlobal agBalance™ solution is ready for immediate availability.
ArisGlobal agBalance™ represents a paradigm shift in how the pharmaceutical industry manages the benefit-risk profile of a drug throughout the drug lifecycle. Until now companies have had to rely on a complex, time consuming process with data scientists, safety leads and regulatory affairs staff to manage and communicate safety concerns from adverse event data. Now, ArisGlobal agBalance™ allows safety experts to directly engage in signal detection and drive the results through signals management into risk management. Regulators and the industry now have access to an integrated platform for detecting safety issues and communicating the changing benefit-risk profile of medicinal products to the health community in a timely manner.
Sharad Prakash, Founder of Medsight and now the Vice President of the newly formed Benefit Risk Management business unit at ArisGlobal® said, “With the ever increasing flow of adverse event data and increasing focus on patient safety, there has never been a greater need to deliver better safety outcomes at the earliest possible point in a product’s lifecycle. Delivered at a similar per-use cost as legacy tools and ad hoc solutions, an organization with ArisGlobal agBalance™ can now achieve a previously unattainable level of risk management productivity. This radically changes the risk management landscape for life sciences products, in the same way that the ‘spinning jenny’ changed production techniques and started the industrial revolution. I really can’t overstate what a change this will bring to pharmacovigilance.”
“Over the years the focus of post-approval management of medicines has changed from risk management to the assessment and management of benefit-risk. In the EU this has been reinforced by changes in the legislation underpinning pharmacovigilance and the introduction of Good Pharmacovigilance Practice (GVP) modules. There is a change in focus for companies and regulators which needs to be reflected in increased cross-functional working and continued benefit-risk assessments. ArisGlobal agBalance™ uses a systematic approach for life cycle benefit-risk assessment thereby assisting life sciences companies in managing the benefit-risk balance of their medicinal products. We are very excited to have ArisGlobal agBalance™ as a key part of our safety portfolio.” said Deepak Abbhi, CEO of ArisGlobal®.
 
 
About ArisGlobal®
For over 25 years ArisGlobal (www.arisglobal.com) has been a leading provider of integrated software solutions for pharmacovigilance and safety, regulatory affairs, clinical research and quality & compliance for medical inquiries. Solutions are available on premise or on a regulated cloud platform.   Life science companies using ArisGlobal’s solutions can better build and maintain the trust they need with their customers, medical practitioners and regulatory bodies around the world.
 
Contact
Kathy Capper
ArisGlobal®
kcapper@arisglobal.com
 
 

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026